... Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS) (Press); Zymeworks Submits Investigational New Drug (IND) Application for ZW49 ...
News
- Recon: Gilead Hires Roche's Pharma Head as New CEO
- Scaleworks co-founder talks venture capital and what he looks for in a CEO
Byrne sat down with the San Antonio Express-News at Scaleworks earlier ... If you're a biotech or energy company, you need venture capital for that.
- Generon Presented Positive Phase III Results From a Double-Blind, Placebo Controlled-Clinical ...
SHANGHAI--(BUSINESS WIRE)--Dec 8, 2018--Generon BioMed Holding ... announced today at the annual San Antonio Breast Cancer Symposium ...
- Meridian Bioscience (VIVO) Shareholder Brown Capital Management Cut Its Stake by $5.16 Million ...
Brown Capital Management Llc decreased its stake in Meridian Bioscience Inc ... Meridian Bioscience, Inc. (NASDAQ:VIVO) has risen 11.66% since ... at San Antonio Breast Cancer Symposium – Nasdaq” published on November 14 ...
- Capital Impact Advisors Has Upped Its Matador Res Co (MTDR) Stake; Meridian Bioscience (VIVO ...
Capital Impact Advisors Llc increased Matador Res Co (MTDR) stake by 28% reported in 2018Q2 SEC filing. Capital Impact Advisors Llc acquired ...